Farther Finance Advisors, LLC Eye Point Pharmaceuticals, Inc. Transaction History
Farther Finance Advisors, LLC
- $9.33 Trillion
- Q4 2025
A detailed history of Farther Finance Advisors, LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 493 shares of EYPT stock, worth $5,842. This represents 0.0% of its overall portfolio holdings.
Number of Shares
493
Previous 602
18.11%
Holding current value
$5,842
Previous $8.57 Million
5.07%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding EYPT
# of Institutions
167Shares Held
69.7MCall Options Held
421KPut Options Held
401K-
Cormorant Asset Management, LP Boston, MA8.33MShares$98.7 Million18.35% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.19MShares$73.4 Million2.57% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.56MShares$65.9 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.82MShares$57.1 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.42MShares$52.3 Million0.12% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $404M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...